DEAN J MITCHELL Insider Trading $XON PRECIGEN, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DEAN J MITCHELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DEAN J MITCHELL. DEAN J MITCHELL is President, U.S. Primary Care in BRISTOL MYERS SQUIBB CO ($BMY) and Director in IMMUNOGEN INC ($IMGN) and Director in INTREXON CORP ($XON) and Director in Theravance Biopharma, Inc. ($TBPH) and Director in Kinnate Biopharma Inc. ($KNTE).
DEAN J MITCHELL in PRECIGEN, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DEAN J MITCHELL: Director
Holdings: 177,926 shares
Current Value: $3,809,396
Latest Transaction: Mar 29 2021
$XON Market Capitalization: $2.53B
$XON Previous Close: $21.41
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DEAN J MITCHELL in PRECIGEN, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BMY, IMGN, KNTE, XON, TBPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Grant | A | 7.71 | 7,328 | 56,499 | 177,926 | 170.6 K to 177.9 K (+4.30 %) |
| Mar 16 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 0.00 | 62,189 | 0 | 0 | |
| Mar 16 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 0.00 | 62,189 | 0 | 170,598 | 108.4 K to 170.6 K (+57.37 %) |
| Mar 05 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 5.69 | 2,968 | 16,888 | 0 | |
| Mar 05 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 5.69 | 2,968 | 16,888 | 108,409 | 105.4 K to 108.4 K (+2.81 %) |
| Jun 23 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 3.17 | 2,968 | 9,409 | 0 | |
| Jun 23 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 3.17 | 2,968 | 9,409 | 105,441 | 102.5 K to 105.4 K (+2.90 %) |
| Mar 17 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 2.01 | 96,324 | 193,611 | 96,324 | |
| Mar 17 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 62,189 | 0 | 62,189 | |
| Mar 17 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Grant | A | 2.01 | 28,109 | 56,499 | 102,473 | 74.4 K to 102.5 K (+37.80 %) |
| Mar 10 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 0.00 | 24,703 | 0 | 0 | |
| Mar 10 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 0.00 | 24,703 | 0 | 74,364 | 49.7 K to 74.4 K (+49.74 %) |
| Mar 26 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | M | 0.00 | 7,911 | 0 | 0 | |
| Mar 26 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Buy | M | 0.00 | 7,911 | 0 | 49,661 | 41.8 K to 49.7 K (+18.95 %) |
| Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | M | 3.17 | 8,906 | 28,232 | 0 | |
| Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 5.06 | 42,450 | 214,797 | 42,450 | |
| Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 24,703 | 0 | 32,614 | |
| Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Buy | M | 3.17 | 8,906 | 28,232 | 41,750 | 32.8 K to 41.8 K (+27.12 %) |
| Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 5.06 | 11,166 | 56,500 | 32,844 | 21.7 K to 32.8 K (+51.51 %) |
| Mar 29 2018 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 15.80 | 14,246 | 225,087 | 14,246 | |
| Mar 29 2018 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 7,911 | 0 | 7,911 | |
| Mar 29 2018 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 15.80 | 3,575 | 56,485 | 21,678 | 18.1 K to 21.7 K (+19.75 %) |
| Aug 11 2017 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Buy | P | 18.33 | 5,000 | 91,640 | 18,103 | 13.1 K to 18.1 K (+38.16 %) |
| Mar 20 2017 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 21.38 | 15,000 | 320,700 | 15,000 | |
| Mar 20 2017 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 0.00 | 3,274 | 0 | 13,103 | 9.8 K to 13.1 K (+33.31 %) |
| Mar 14 2016 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 34.99 | 15,000 | 524,850 | 15,000 | |
| Mar 14 2016 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 34.99 | 2,000 | 69,980 | 9,829 | 7.8 K to 9.8 K (+25.55 %) |
| Mar 23 2015 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 47.48 | 15,000 | 712,200 | 15,000 | |
| Mar 23 2015 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 47.48 | 1,474 | 69,986 | 7,829 | 6.4 K to 7.8 K (+23.19 %) |
Page: 1